Eikon Therapeutics, Inc.
EIKN
$12.31
$0.786.77%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 17.73M | 13.92M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 82.96M | 67.78M | |||
| Operating Income | -82.96M | -67.78M | |||
| Income Before Tax | -79.66M | -64.92M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -79.66M | -64.92M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.66M | -64.92M | |||
| EBIT | -82.96M | -67.78M | |||
| EBITDA | -77.57M | -64.00M | |||
| EPS Basic | -26.38 | -24.34 | |||
| Normalized Basic EPS | -16.44 | -15.21 | |||
| EPS Diluted | -26.38 | -24.34 | |||
| Normalized Diluted EPS | -16.44 | -15.21 | |||
| Average Basic Shares Outstanding | 3.02M | 2.67M | |||
| Average Diluted Shares Outstanding | 3.02M | 2.67M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||